Katalóg evidencie publikačnej činnosti PU


ID záznamu:PU.Prešov.2017102811441382
Kategória:ADC
Autor:Nieuwlaat R. (0%)
Autor:Capucci A. (0%)
Autor:Camm A.J. (0%)
Autor:Olsson S.B. (0%)
Autor:Andersen D. (0%)
Autor:Kmec Ján (0%)
Názov:Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation
Zdroj:European heart journal
Lokácia:Vol. 26, no. 22 (2005), s. 2422-2434
ISSN:0195-668X
Ohlas:[1] 2017. TEMU, T.M., LANE, K.A., SHEN, C. et al. Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya. In PLoS ONE, ISSN 1932-6203. 2017, vol. 12, no. 9, art. no. e0185204.
Ohlas:[1] 2017. GÓMEZ, M.V., GRANERO, C.L., MUNOZ, D.R. et al. Atrial fibrillation and atrial flutter. In Medicine (Spain), ISSN 0304-5412. 2017, vol. 12, no. 39, s. 2299-2308.
Ohlas:[1] 2017. MESTER, P., DOMPNIER, A., BELLE, L. Asymptomatic migration of an AMPLATZER™ Amulet™ left atrial appendage occluder through the mitral valve. In Catheterization and cardiovascular interventions, ISSN 1522-1946. 2017, vol. 90, no. 2, s. 346-349.
Ohlas:[1] 2017. PIPILIS, A., FARMAKIS, D., KALIAMBAKOS, S. et al. Anticoagulation therapy in elderly patients with atrial fibrillation: Results from the registry of atrial fibrillation to investigate the implementation of new guidelines (RAFTING). In Journal of cardiovascular medicine, ISSN 1558-2027. 2017, vol. 18, no. 7, s. 545-549.
Ohlas:[1] 2017. ZACK, C.J., FENDER, E.A., HOLMES, D.R. Stroke prevention in atrial fibrillation with left atrial appendage closure. In Minerva medica, ISSN 0026-4806. 2017, vol. 108, no. 3, s. 199-211.
Ohlas:[1] 2017. MOTLOCH, L.J., REDA, S., LARBIG, R. et al. Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm. In Hellenic journal of cardiology, ISSN 1109-9666. 2017, vol. 58, no. 3, s. 204-212.
Ohlas:[1] 2017. NARDI, F., GULIZIA, M.M., COLIVICCHI, F. et al. ANMCO Position Paper: Direct oral anticoagulants for stroke prevention in atrial fibrillation: Clinical scenarios and future perspectives. In European heart journal, ISSN 1520-765X. 2017, vol. 19, suppl. s. D70-D88.
Ohlas:[1] 2017. HANNON, O., VIDAL, J.-S., LE HEUZEY, J.-Y. et al. Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF. In International journal of cardiology, ISSN 0167-5273. 2017, vol. 232, s. 98-104.
Ohlas:[1] 2017. ZIRLIK, A., BODE, C. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. In Journal of thrombosis and thrombolysis, ISSN 0929-5305. 2017, vol. 43, no. 3, s. 365-379.
Ohlas:[1] 2017. ALIPOUR, A., WINTGENS, L.I.S., SWAANS, L.I.S. Novel stroke risk reduction in atrial fibrillation: Left atrial appendage occlusion with a focus on the Watchman closure device. In Vascular health and risk management, ISSN 1176-6344. 2017, vol. 13, s. 81-90.
Ohlas:[1] 2017. ZHENG, H.J., OUYANG, S.K., ZHAO, Y. et al. The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China. In International journal of general medicine, ISSN 1178-7074. 2017, vol. 10, s. 69-77.
Ohlas:[1] 2017. PFEIFFER, D., NEEF, M. Komplikationen elektrophysiologischer Eingriffe im Alter. In Herzschrittmachertherapie und Elektrophysiologie, ISSN 0938-7412. 2017, vol. 28, no. 1, s. 3-8.
Ohlas:[1] 2017. EKIZLER, A., ARAS, D., CAY, S. et al. Bonus vs no bonus cryoballoon isolation for paroxysmal atrial fibrillation ablation. In Journal of atrial fibrillation, ISSN 1941-6911. 2017, vol. 9, no. 5.
Ohlas:[1] 2017. LEE, C.-H., LIN, T.-Y., CHANG, S.-H. et al. Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran. In International journal of cardiology, ISSN 0167-5273. 2017, vol. 228, s. 771-778.
Ohlas:[1] 2017. MAZUREK, M., HUISMAN, M.V., LIP, G.Y.H. Registries in atrial fibrillation: From trials to real-life clinical practice. In American journal of medicine, ISSN 0002-9343. 2017, vol. 130, no. 2, s. 135-145.
Ohlas:[1] 2017. SAHAY, S., NOMBELA-FRANCO, L., RODES-CABAU, J. et al. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: A network meta-analysis from randomised trials. In Heart, ISSN 1355-6037. 2017, vol. 103, no. 2, s. 139-147.
Ohlas:[1] 2017. ASPROMONTE, N., COLIVICCHI, F. Clinical relevance of pharmacokinetic and pharmacodynamic properties of edoxaban when treating patients with atrial fibrillation and heart failure. In Expert opinion on drug metabolism and toxicology, ISSN 1742-5255. 2017, vol. 13, no. 1, s. 113-122.
Ohlas:[1] 2017. WITKOWSKI, M., STEFFENS, D., HASSANEIN, A. et al. Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?. In Thrombosis research, ISSN 0049-3848. 2017, vol. 149, s. 62-63.
Ohlas:[1] 2017. RAČKAUSKAS, G., ZABIELA, V., MARINSKIS, G. et al. Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey. In Medicina (Lithuana), ISSN 1010-660X. 2017, vol. 53, no. 1, s. 19-25.
Ohlas:[1] 2017. LIAO, Y., LIAO, J., LO, L. et al. Left atrial size and left ventricular end-systolic dimension predict the progression of paroxysmal atrial fibrillation after catheter ablation. In Journal of cardiovascular electrophysiology, ISSN 1045-3873. 2017, vol. 28, no. 1, s. 23-30.
Ohlas:[1] 2017. YAVUZ, B., ATA, N., OTO, E. et al. Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort. In Europace, ISSN 1099-5129. 2017, vol. 19, no. 5, s. 734-740.
Ohlas:[1] 2017. GIANNI, C., DI BIASE, L., MOHANTY, S. et al. How to improve cardiac resynchronization therapy benefit in atrial fibrillation patients: pulmonary vein isolation (and beyond). In Heart failure clinics, ISSN 1551-7136. 2017, vol. 13, no. 1, s. 199-208.
Ohlas:[1] 2017. CEORNODOLEA, A.D., BAL, R., SEVERENS, J.L. Epidemiology and management of atrial fibrillation and stroke: Review of data from four European countries. In Stroke research and treatment, ISSN 2090-8105. 2017, art. no. 8593207.
Ohlas:[1] 2017. VOUKALIS, C., SHANTSILA, E., LIP, G.Y.H. Stroke prevention in atrial fibrillation. In The journal of the Royal College of Physicians of Edinburgh, ISSN 1478-2715. 2017, vol. 47, no. 1, s. 13-23.
Oblasť výskumu:180